Home
Thyrocare Technologies Ltd Quarterly Result

Thyrocare Technologies Ltd
NSE: THYROCARE
Net Profit - Last Quarter
Thyrocare Technologies Ltd Quarterly Results Key Highlights
- The revenue of Thyrocare Technologies Ltd for the Mar '25 is ₹ 191.75 crore as compare to the Dec '24 revenue of ₹ 169.93 crore.
- This represent the growth of 12.84%a1# The ebitda of Thyrocare Technologies Ltd for the Mar '25 is ₹ 61.66 crore as compare to the Dec '24 ebitda of ₹ 45.58 crore.
- This represent the growth of 35.28%a1# The net profit of Thyrocare Technologies Ltd for the Mar '25 is ₹ 21.57 crore as compare to the Dec '24 net profit of ₹ 18.95 crore.
- This represent the growth of 13.83%a1#.
Thyrocare Technologies Ltd Quarterly Results Analysis
Market Price of Thyrocare Technologies Ltd
1M
1Y
3Y
5Y
Monitoring Thyrocare Technologies Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
Last Ten Days Market Price
Date | |
---|---|
23 Apr 2025 | 768.85 |
22 Apr 2025 | 794.3 |
21 Apr 2025 | 730.8 |
17 Apr 2025 | 709 |
16 Apr 2025 | 707.65 |
15 Apr 2025 | 713.4 |
11 Apr 2025 | 703 |
09 Apr 2025 | 705.55 |
08 Apr 2025 | 684.35 |
07 Apr 2025 | 677.55 |
×
Historical Net Profit of Thyrocare Technologies Ltd
Historical Net Profit of Thyrocare Technologies Ltd
Thyrocare Technologies Ltd News Hub
Thyrocare Technologies AGM scheduled
Thyrocare Technologies announced that the Annual General Meeting (AGM) of the company will be held o
Read more
06 Aug 24
Thyrocare Tech to acquire diagnostic and pathological services of Vimta Lab
Thyrocare Technologies said that it shall have access to 11 centres of Vimta Labs at the locations s
Read more
30 Aug 24
Thyrocare to acquire diagnostic and pathological services of Vimta Lab
Thyrocare Technologies has signed a Business Transfer Agreement for purchase of the diagnostic and p
Read more
30 Aug 24
Thyrocare Technologies announces cessation of director
Thyrocare Technologies announced the cessation of Neetin Shivajirao Desai (DIN No: 02622364) as Inde
Read more
19 Sept 24
Document
Popular Search
FAQs for Quarterly Results of Thyrocare Technologies Ltd
What key financial metrics are included in Thyrocare Technologies Ltd's quarterly results?
Key financial metrics in Thyrocare Technologies Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.
When does Thyrocare Technologies Ltd announce its quarterly results?
Thyrocare Technologies Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.
How does Thyrocare Technologies Ltd's quarterly performance impact its stock price?
Thyrocare Technologies Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.
What is the impact of Thyrocare Technologies Ltd's quarterly results on dividends?
The impact of Thyrocare Technologies Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.
Are there any special announcements usually made during Thyrocare Technologies Ltd's quarterly results?
Yes, Thyrocare Technologies Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.